# Indena S.p.A., Settala, Italy – FDA Inspections

Source: https://www.keypedia.com/companies/indena-spa/bc7187ac-74c4-4f04-bd1c-0d888424e076

> Inspection records and compliance data for Indena S.p.A. in Settala. 8 FDA inspections on record, last inspected November 26, 2021.

---

## Details

- Name: Indena S.p.A.
- FEI Number: 1000280888
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, REPACK
- Address Line 1: Via Don Giovanni Minzoni 6
- City: Settala
- Country Name: Italy
- Address: Via Don Giovanni Minzoni 6, Settala, Italy
- Country: Italy

## Related Documents

- [483 - Indena S.p.A. - Unknown Date](https://www.keypedia.com/records/483/indena-spa/7e415097-5c9d-452d-a7ae-474e4513041e) — source: FDA, date: Invalid Date
- FDA Inspection 1193895 - Indena S.p.A. - 2021-11-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 26, 2021
- FDA Inspection 1072831 - Indena S.p.A. - 2018-05-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2018
- FDA Inspection 982504 - Indena S.p.A. - 2016-07-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 29, 2016
- FDA Inspection 877297 - Indena S.p.A. - 2014-04-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2014
- FDA Inspection 722394 - Indena S.p.A. - 2011-03-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2011
- FDA Inspection 722394 - Indena S.p.A. - 2011-03-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2011
- FDA Inspection 722394 - Indena S.p.A. - 2011-03-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2011
- FDA Inspection 735965 - Indena S.p.A. - 2011-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2011
- FDA Inspection 735965 - Indena S.p.A. - 2011-03-30 — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2011
- FDA Inspection 546193 - Indena S.p.A. - 2008-10-16 — classification: No Action Indicated (NAI), source: FDA, date: October 16, 2008

## Related Companies

- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad)
- [FIS - Fabbrica Italiana Sintetici S.p.A.](https://www.keypedia.com/companies/fis-fabbrica-italiana-sintetici-spa/b9e7c30e-9955-4095-aae6-e40efd92c3c0)
- [Hovione Limited](https://www.keypedia.com/companies/hovione-limited/cf05e9e2-8ff4-41e2-a547-34c4f03eaef5)
- [Syngene International Ltd.](https://www.keypedia.com/companies/syngene-international-ltd/11ddfe19-cf6b-48b5-b7ab-8e3236ac3636)
- [Fresenius Kabi AB](https://www.keypedia.com/companies/fresenius-kabi-ab/95acd39b-72be-48a9-aa55-38713a33c8cc)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177)
- [Genzyme Flanders](https://www.keypedia.com/companies/genzyme-flanders/5f71d574-8097-4cd8-9254-2f8b85700e59)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)
- [Janssen Pharmaceutica N.V.](https://www.keypedia.com/companies/janssen-pharmaceutica-nv/2497eb89-133e-4154-a106-1c7a182b6f00)

## Related Officers

- [Investigator](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)
- [Consumer Safety Officer](https://www.keypedia.com/people/sangeeta-m-khurana/bed4533f-a9aa-47c5-9e0b-f20ad36461aa)
